Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.50
Ask: 42.50
Change: -0.30 (-0.71%)
Spread: 1.00 (2.41%)
Open: 41.75
High: 41.70
Low: 41.70
Prev. Close: 42.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

24 Aug 2005 07:00

Readybuy PLC24 August 2005 READYBUY PLCPRELIMINARY RESULTSYear ended 30 April 2005 CHAIRMAN'S STATEMENT Results Our results for the year ended 30 April 2005 show turnover of £313,000 (2004:£19,000) and operating losses of £252,000 (2004: £343,000). Furthermore, as theboard has decided to withdraw from food manufacturing, additional provisions of£804,000 have been made at the year-end. These relate to the write-off ofgoodwill and the write-down of machinery values. Although some progress was made during the year and several listings wereachieved, the level of business was not sufficient to maintain a viablemanufacturing unit. Since the year-end, the manufacturing unit has been closed and the machinery hasbeen sold. Paul Bennett, the Chief Executive, left the company on 22 July and we wish tothank him for his efforts in trying to build the business. The board is now considering the options available to the Group and will updateshareholders in due course. I would like to thank all the employees for their hard work during the difficulttrading period Colin DaviesChairman24 August 2005 READYBUY PLC CONSOLIDATED PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED 30 APRIL 2005 Audited Audited 01/05/04 to 30/04/05 01/05/03 to 30/04/04 £000's £000'sTurnover 313 19 Operating Loss (252) (343) Provision for loss on operations to be discontinued (804) - (1056) (343)Interest Payable (4) (6)Interest Receivable 2 6 Loss before Taxation (1058) (343) Taxation (45) 45 Loss after taxation (1103) (298)Dividends - -Deficit for the year (1103) (298) Loss Per Share (note 3) (6.1p) (2.2p) The Group's trading activities were terminated in July 2005, therefore all ofthe above activities are classified as discontinued. READYBUY PLC CONSOLIDATED BALANCE SHEET AT 30 APRIL 2005 Audited Audited 30 April 2005 30 April 2004 £000's £000'sFixed AssetsIntangible Assets - 646Tangible Assets - 218 - 864Current AssetsStocks 2 7Debtors 44 82Cash at Bank and in Hand 169 429 215 518 Creditors: amounts due within one year (194) (323) Net current assets 21 195Total assets less current liabilities 21 1059Creditors: amounts falling due after more than one year - (25) Net Assets 21 1034 Share Capital and ReservesCalled up Share Capital 93 90Share Premium Account 1329 1242Profit and Loss Account (1401) (298) Equity and Non-Equity Shareholders' funds 21 1034 READYBUY PLC CONSOLIDATED CASHFLOW STATEMENT FOR THE YEAR ENDED 30 APRIL 2005 Audited Audited 01/05/04 to 30/04/05 01/05/03 to 30/04/04 £000's £000's Net Cash outflow from operating activities (80) (407) Returns on investments and servicing of financeInterest Paid (4) (6)Interest Received 2 6Net Cash Inflow/(Outflow) from servicing of (2) -Finance Capital Expenditure Payments to acquire tangible assets (9) (77)Sale of tangible assets 1 35 Net Cash outflow from Capital Expenditure (8) (42) Purchase of Subsidiary undertaking - (272)Net overdraft acquired with subsidiary undertaking - (6)Net Outflow from acquisitions - (278) Net Cash outflow before use of (90) (727)liquid resources and financing Financing Issue of equity Share Capital 90 1169Capital element of lease payments (34) (19)Repayment of term loans - (220)Net Inflow from financing 56 930 (Decrease)/Increase in Cash (34) 203 READYBUY PLCFOR THE YEAR ENDED 30 APRIL 2005 Notes 1. The preliminary financial results for the year ended 30 April 2005 were approved by the Directors on 24 August 2005. 2. There were no recognised gains or losses other than the result for the period. 3. The calculation of earnings per share is based upon the loss after taxation of £1,103,000 (2004: £298,000) divided by the weighted average number of ordinary shares in issue during the year which was 18,066,870 (2004: 13,585,434). 4. The preliminary statement is available from the Company's registered office at: Television House, 10-12 Mount Street, Manchester, M2 5NT. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd May 20247:00 amRNSSuccessful Completion of First Cohort
30th Apr 20247:01 amRNSFull Year Results
30th Apr 20247:00 amRNSBoard Change
26th Apr 20249:51 amRNSBlock listing Interim Return REPLACEMENT
26th Apr 20247:00 amRNSBlock Listing Six Monthly Return
23rd Apr 20249:43 amRNSBlock Listing Application to AIM
23rd Apr 20247:00 amRNSNotice of Results
22nd Apr 202412:14 pmRNSIssue of Equity and Total Voting Rights
9th Apr 20245:00 pmRNSAvacta Reports Data at the AACR Annual Meeting
8th Apr 20247:00 amRNSAVA6000 Abstract Release by AACR
28th Mar 20244:00 pmRNSInvestor Webinar
21st Mar 20247:00 amRNSUpdate on AVA6000 Phase 1a Clinical Trial Progress
18th Mar 20241:26 pmRNSResult of General Meeting
6th Mar 20247:00 amRNSAvacta Announces AVA6000 Poster at AACR
5th Mar 20247:00 amRNSResult of REX Retail Offer
29th Feb 20247:00 amRNSResult of Placing
28th Feb 20244:42 pmRNSProposed REX Retail Offer
28th Feb 20244:41 pmRNSProposed Fundraise to progress Therapeutics
16th Feb 20247:00 amRNSShare Incentive Plan/Issue of Equity
22nd Jan 202410:51 amRNSIssue of Equity and Total Voting Rights
19th Jan 20247:00 amRNSAppointment of Christina Coughlin
19th Dec 20237:00 amRNSAppointment of Chief Business Officer
13th Dec 20237:00 amRNSALS-6000-101 Phase 1a Study Data
4th Dec 20237:00 amRNSShareholder update to review AVA6000 Phase 1a data
27th Oct 20237:00 amRNSBlock Listing Six Monthly Return
23rd Oct 20231:30 pmRNSIssue of Equity and Total Voting Rights
18th Oct 20231:00 pmRNSBlock Listing Application to AIM
5th Oct 20237:00 amRNSAvacta to present at AACR-NCI-EORTC conference
28th Sep 20237:00 amRNSInterim Results for the Period Ending 30 June 2023
20th Sep 20232:00 pmRNSIssue of Equity and Total Voting Rights
20th Sep 20237:01 amRNSPeel Hunt Appointed as Joint Broker
20th Sep 20237:00 amRNSAppointment Dr.Christina Coughlin as a consultant
19th Sep 20237:00 amRNSSuccessful Completion of Sixth Dose Escalation
6th Sep 20237:00 amRNSNotice of Results
21st Jul 20233:00 pmRNSIssue of Equity and Total Voting Rights
28th Jun 202311:00 amRNSResult of Annual General Meeting
28th Jun 20237:00 amRNSAnnual General Meeting and Shareholder Event
21st Jun 20237:00 amRNSCompletion of Fifth Dose Escalation in AVA6000
19th Jun 20237:01 amRNSDirector Appointment
19th Jun 20237:00 amRNSStatement regarding market speculation
8th Jun 20237:00 amRNSAGM and Shareholder Event Detailed Agenda
5th Jun 20237:00 amRNSSecond Milestone in AffyXell Joint Venture
2nd Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSAvacta acquires Coris Bioconcept
27th Apr 20237:00 amRNSBlock Listing Six Monthly Return
27th Apr 20237:00 amRNSFirst Patient Dosed in the US in AVA6000 Phase 1
25th Apr 20237:00 amRNSPreliminary Results
21st Apr 20232:49 pmRNSIssue of Equity and Total Voting Rights
17th Apr 20237:00 amRNSAVA3996 data poster presented at AACR
6th Apr 20237:00 amRNS1st US Clinical Investigator AVA6000 Sites Opened

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.